CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...